Definitions - WHO
3 Pharmacovigilance WHO, 2002 • The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-
Download Definitions - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
for Measuring Adverse Events - IHI
app.ihi.orgIHI Global Trigger Tool for Measuring Adverse Events Second Edition Innovation Series 2009 Authors: Frances A. Griffin, RRT, MPA:Director, IHI …
Adverse Childhood Events as Risk Factors for …
theannainstitute.orgPSYCHIATRIC ANNALS 37:5 | MAY 2007 359 Adverse Childhood Events as Risk Factors for Negative Mental Health Outcomes T he successful resolution of …
Questions and answers on adverse event reporting
www.ema.europa.euQuestions and answers on adverse event reporting EMA/CVMP/PhVWP/145186/2013-Rev.3 Page 2/3 3. How should lack of expected efficacy (LEE) events be coded following use of euthanasia
25 Understanding Adverse Events - ICSSC
www.icssc.orgGoals of the Presentation UNDERSTANDING: Definition of Adverse Event Expected vs. Unexpected Adverse Event Definition of SERIOUS Adverse Events Intensity vs. Seriousness of Adverse Events
Improving Patient Understanding at Discharge: …
www.ihi.orgImproving Patient Understanding at Discharge: Medical Student Enhanced Patient Education Justin Slade, MS4, Lakshman Swamy, MD, Warren Hershman, MD, MPH, Britt Simonson, M.Ed. and Karin Sloan, MD
When Things Wrong - macoalition.org
www.macoalition.orgIn March 2004, responding to evidence of wide variation in the way both Harvard hospitals and hospitals nationally communicate with patients about errors and adverse events…